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Modulation of Cell–Fibronectin Matrix Interactions
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Kim S. Midwood2, Yong Mao1, Henry C. Hsia1,3, Leyla V. Valenick1 and Jean E. Schwarzbauer1
Environmental signals from the extracellular matrix (ECM) are transmitted by cell surface receptors that connect
to the actin cytoskeleton and to multiple intracellular signaling pathways. To dissect how the ECM regulates cell
functions, we are using a three-dimensional (3D) fibrin–fibronectin matrix, resembling the wound provisional
matrix. Fibroblasts adhere to fibronectin in this matrix via concomitant engagement of a5b1 integrin receptors
and syndecan-4, a transmembrane proteoglycan. An adhesive phenotype is developed with actin stress fibers
and activation of focal adhesion kinase (FAK) and Rho GTPase. Lack of syndecan-4 engagement, as occurs in the
presence of the ECM protein tenascin-C, promotes a motile phenotype; FAK and Rho signaling are
downregulated and filopodia are extended. Fibronectin matrices have distinct effects on two other receptors:
a4b1 and avb3 integrins. Although a4b1 does not naturally support strong cell interactions with a
fibrin–fibronectin matrix, binding is dramatically enhanced by proteolytic cleavage of fibronectin. Conversely,
activity of avb3 is stimulated by multimeric fibronectin fibrils showing that the organization of fibronectin
differentially affects integrin functions. Thus, deposition of additional ECM components, expression of co-
receptors for ECM, cleavage of adhesive proteins, and the architecture of the ECM microenvironment are
different mechanisms for modulating cell responses to fibronectin matrix.
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INTRODUCTION
Wound repair is a dynamic process requiring orchestrated cell
movements, ECM deposition and degradation, and changes in
cell signaling and gene expression. The adhesive ECM protein
fibronectin is present throughout sites of tissue injury, being
deposited initially during blood coagulation as a major compo-
nent of the provisional matrix, then released by neutrophils
and macrophages, and subsequently assembled by fibroblasts
and endothelial cells to form granulation tissue (Hynes, 1990;
Clark, 1996). Modulation of fibronectin expression and depo-
sition provides temporal and spatial cues to direct cell adhesive
activities as repair progresses. Fibronectin mediates cell adhe-
sion primarily through heterodimeric integrin receptors includ-
ing a5b1, which binds to the arg-gly-asp (RGD) and adjacent
sequences in the central cell binding domain and a4b1, which
recognizes the CS1 site within the alternatively spliced V region
(Pankov and Yamada, 2002; Mao and Schwarzbauer, 2005a).
Cell binding to fibronectin promotes cytoskeletal organization
and intracellular signaling (Hynes, 2002) and connects cells to
other matrix components such as collagen, fibrin, and
glycosaminoglycans (Mao and Schwarzbauer, 2005a).
Adhesion modulatory proteins, such as tenascin-C (Chiquet-
Ehrismann and Chiquet, 2003; Hsia and Schwarzbauer,
2005), are also found in the wound bed and counterbalance
the activities of fibronectin and other adhesive proteins in
vitro. Tenascin-C is a large multidomain ECM protein with
binding sites for cell receptors, fibronectin, and glycos-
aminoglycans. In cell culture, tenascin-C induces loss of focal
adhesions and prevents cell adhesion and spreading on
fibronectin (Chiquet-Ehrismann et al., 1988; Murphy-Ullrich
et al., 1991).
Our work has focused on modulation of fibronectin inter-
actions with cells throughout the repair process. We have
developed three-dimensional (3D) matrix models that re-
semble the fibrin–fibronectin provisional matrix and the
fibrillar fibronectin matrix found in granulation tissue. We
are using these models to study the complex interplay
between adhesion, adhesion modulation, and matrix turn-
over during repair and have identified specific molecular
changes and intracellular signaling pathways that play critical
regulatory roles. Some of these results are described in this
review of our work.
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PROVISIONAL MATRIX MODEL
At sites of tissue damage, the blood coagulation cascade
deposits a covalently crosslinked fibrin–fibronectin provi-
sional matrix, which prevents further blood loss and acts as a
framework for cell adhesion and migration during repair.
Polymerization of the fibrin–fibronectin matrix can be
recapitulated in vitro using purified components (Mosher,
1976; Wilson and Schwarzbauer, 1992; Corbett et al., 1996).
To examine cell responses to a 3D fibrin–fibronectin matrix,
we use immunofluorescence microscopy of cells plated on
top of the fibrin–fibronectin matrix to determine protein
localization and cell shape. Cell lysates are analyzed for
changes in intracellular signaling. This 3D matrix also
provides a system for dissecting the regulation of matrix
contraction. Cells included during the polymerization reac-
tion become embedded in the 3D matrix and cell contrac-
tility is measured by size changes of the matrix over time to
give the % contraction (Corbett and Schwarzbauer, 1999;
Midwood and Schwarzbauer, 2002). The contraction assay
provides a quantitative measure of cell–matrix interactions to
complement the more qualitative microscopic data.
MODULATION OF PROVISIONAL MATRIX FUNCTION
BY TENASCIN-C
During adult dermal repair, tenascin-C is specifically induced
within 24 hours of wounding (Mackie et al., 1988; Betz et al.,
1993; Forsberg et al., 1996) and is found near the wound
edge where it contacts fibronectin and other provisional
matrix components. Tenascin-C has been shown to anta-
gonize fibronectin function in vitro (Chiquet-Ehrismann et al.,
1988; Chiquet-Ehrismann and Chiquet, 2003), which
prompted us to examine its effects on fibroblast morphology
in response to a 3D fibrin–fibronectin matrix. We observed
dramatic changes in the presence of tenascin-C. Cell
spreading and actin stress fiber formation were inhibited;
cells remained rounded and extended actin-rich filopodia. In
our model system, tenascin-C regulation of Rho GTPase
activity was responsible for these changes in the cytoskele-
ton. The Rho family of GTPases controls actin organization:
activation of family members RhoA, Rac, and Cdc42
promotes stress fiber, lamellipodia, and filopodia formation,
respectively (Hall, 2005). We demonstrated that tenascin-C
suppressed RhoA activity but not Rac or Cdc42 (Wenk et al.,
2000). This implies that tenascin-C-mediated control of the
cytoskeleton occurs via inhibition of stress fiber formation, as
opposed to stimulation of filopodia or destabilization of actin,
as has since been reported in other models (Orend et al.,
2003). Tenascin-C also inhibited focal adhesion assembly in
cells on a 3D fibrin-fibronectin matrix by suppressing the
activation of focal adhesion kinase (FAK) (Midwood and
Schwarzbauer, 2002). FAK is a nonreceptor tyrosine kinase
that regulates the turnover of focal adhesions (Ilic et al., 2004)
and is rapidly activated in response to fibronectin–integrin
interactions (Mitra et al., 2005).
The phenotype induced by tenascin-C is indicative of a
migratory cell. Both FAK and RhoA play vital roles in cell
migration, regulating the cell adhesion, traction, and con-
tractility required for cell movement (Mitra et al., 2005). By
modulating their activities, tenascin-C may promote fibro-
blast migration from undamaged tissue at the wound edge
into the wound bed. This hypothesis is supported by the
phenotype of tenascin-C null mice, which although normal in
development, viability, and fertility, show some severe
defects in tissue repair. These mice exhibit compromised
cell migration and proliferation in corneal wounds and in
induced glomerulonephritis and dermatitis (Mackie and
Tucker, 1999).
In the latter stages of dermal wound repair, tenascin-C is
detected in granulation tissue but is not present in scar tissue
after wound contraction (Mackie et al., 1988; Betz et al.,
1993). Given that RhoA activity is essential for cell
contractility (Hall, 1998), we examined whether tenascin-C
had any effect on matrix contraction. The inclusion of
tenascin-C in a fibrin–fibronectin matrix inhibited fibroblas-
t-mediated contraction due to defects in signaling via both
RhoA GTPase and FAK-mediated pathways. Activation of
either alone partially relieved the effects of tenascin-C, but to
regain optimal contractile ability required activation of both
FAK and RhoA simultaneously (Midwood and Schwarzbauer,
2002). These data suggest that tenascin-C expression in the
wound bed up to the point of wound closure prevents
premature wound contraction. Downregulation of tenascin-C
expression and clearance from the wound would then allow
contraction to proceed indicating that tenascin-C exerts
temporal control over cell behavior during wound healing.
ECM COMMUNICATION THROUGH CELL SURFACE
RECEPTORS
Fibroblast binding to fibronectin within the 3D provisional
matrix requires a5b1 integrins (Corbett and Schwarzbauer,
1999). Evidence that a heparan sulfate proteoglycan also
participates in fibroblast interactions was obtained when we
compromised heparan sulfate proteoglycan function by
competition with soluble heparin or treatment of cells with
heparitinase. Both treatments induced a phenotype similar to
tenascin-C. a5b1 integrin acts together with the cell surface
heparan sulfate proteoglycan syndecan-4 for cell spreading
and signaling in fibroblasts on fibronectin-coated surfaces
(Saoncella et al., 1999; Bass and Humphries, 2002).
Syndecan-4 is expressed at low levels in nearly every cell
type (Bernfield et al., 1999), but is transiently upregulated
upon injury. Increased expression has been observed in the
dermis adjacent to the injury, in migratory keratinocytes at
the edges of the wound, as well as throughout the granulation
tissue on endothelial cells and fibroblasts (Gallo et al., 1994;
Gallo et al., 1996).
Syndecan-4-null mouse embryo fibroblasts were used to
assess its role in fibroblast response to the 3D fibrin-
fibronectin matrix. Null cells had a distinct morphology and
impaired contraction of the provisional matrix compared to
wild-type fibroblasts. Like wild-type cells cultured in the
presence of tenascin-C, cells lacking syndecan-4 extended
actin-rich filopodia (Midwood et al., 2004) and failed to
activate RhoA and FAK signaling pathways (Wilcox-Adelman
et al., 2002). These signaling deficiencies are directly
responsible for reduced matrix contraction and were rescued
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by re-expression of syndecan-4 (Midwood et al., 2004). These
data show that the coordinated interaction of fibronectin with
syndecan-4 and a5b1 integrins is essential for effective cell
response to the provisional matrix. The mechanisms of
syndecan-4 action identified using model systems are
consistent with results from mice with targeted deletion of
syndecan-4. Like tenascin-C-null mice, syndecan-4-deficient
mice develop normally but show defects in wound healing.
Repair of excisional skin wounds is delayed in the first 7 days:
re-epithelialization is retarded, there is reduced accumula-
tion of granulation tissue, and no wound contraction
(Echtermeyer et al., 2001).
In our experiments, cell phenotype in the presence of
tenascin-C resembled that of cells with compromised
syndecan-4 expression or function. Furthermore, tenascin-C
binds to the HepII domain in fibronectin (Huang et al., 2001),
as does syndecan-4 (Woods et al., 2000). These observations
suggested that tenascin-C acts by inhibiting syndecan-
4–fibronectin interactions. In support of this model, we found
that, in contrast to wild-type fibroblasts, syndecan-4-null cells
were able to spread and organize the actin cytoskeleton on a
fibrin–fibronectin matrix containing tenascin-C. This shows
that cell response to tenascin-C requires expression of
syndecan-4 (Midwood et al., 2004). Conversely, overexpre-
ssion of syndecan-4 circumvented the effects of tenascin-C
and restored fibronectin-mediated cell spreading, matrix
contraction (Midwood et al., 2004), and proliferation (Huang
et al., 2001; Orend et al., 2003). Therefore, the effects of
tenascin-C on cell functions result from blockade of
fibronectin signaling through syndecan-4. During wound
repair, changes in tenascin-C and/or syndecan-4 expression
may act as a regulatory switch to modulate cell–fibronectin
interactions and determine the levels of cell growth and
matrix contraction.
These results suggest the following model to explain
certain cell behaviors during the early stages of repair
(Figure 1). Fibroblasts emigrate to the wound bed from
surrounding tissue. In areas adjacent to the injury, cells
encounter the fibrin–fibronectin provisional matrix (Clark
et al., 2003) and newly synthesized tenascin-C (Forsberg
et al., 1996). a5b1 integrin binds to fibronectin but the
presence of tenascin-C induces a motile cell phenotype by
blocking syndecan-4 binding to fibronectin, thus suppressing
Rho GTPase and FAK activities (Figure 1a, left). These signals
promote cell migration and prevent inappropriate matrix
contraction at the extremes of the wound. As cells move
further into the wound bed, tenascin-C levels are reduced.
Fibronectin interactions with a5b1 integrin and syndecan-4
stimulate cell spreading and formation of stress fibers and
focal adhesions via RhoA and FAK activation and promote
enhanced cell contractility in order to close the wound
(Figure 1b, left).
a4b1 INTEGRIN INTERACTIONS WITH FIBRONECTIN IN
A PROVISIONAL MATRIX
Many blood cells express the a4b1 integrin receptor for
fibronectin. For example, a4b1-positive neutrophils rapidly
emigrate to wound sites and are one of the first cells to arrive
(Clark, 1996). However, these cells also express a5b1
integrin. To focus specifically on a4b1 activities, we used
CHO cell transfectants expressing a4b1 as their fibronectin
receptor (CHOa4) and compared their behaviors to CHO
cells expressing a5b1 (CHOa5). The RGD and synergy
sequences comprise the binding site for a5b1 on fibronectin
while a4b1 binds to the CS1 segment of the alternatively
spliced V region (Hynes, 1990). This site is found in roughly
half of plasma fibronectin subunits whereas fibroblasts
synthesize fibronectin with more than 90% Vþ subunits.
Therefore, as the provisional matrix is replaced by granula-
tion tissue, the number of potential binding sites for a4b1-
positive cells increases.
Using the provisional matrix model, we compared CHOa4
and CHOa5 cell adhesion and matrix contraction. As
previously reported, CHOa5 cells attach to, spread on, and
contract fibrin–fibronectin 3D matrices (Corbett and Schwarz-
bauer, 1999). Surprisingly, a4b1-mediated adhesion on this
3D matrix was limited and CHOa4 cells were incapable of
contracting the matrix (Valenick et al., 2005). Both cell lines
attached and spread on two-dimensional (2D) substrates of
fibronectin showing that the receptors are functional. a4b1
belongs to a class of integrins that requires activation for full
functional activity (Masumoto and Hemler, 1993; Hynes,
2002). Activation naturally occurs through interactions with
cytoplasmic or transmembrane proteins, many of which have
Figure 1. Modulation of cell interactions with fibronectin matrices.
(a) Adhesion, spreading, and contraction mediated by a5b1 integrin and
syndecan-4 are reduced with deposition of tenascin-C into a 3D fibrin–fi-
bronectin matrix (left). By blocking syndecan-4 binding to fibronectin,
tenascin-C downregulates signaling through FAK and Rho GTPase. Cells
expressing a4b1 integrin show reduced adhesion and are unable to spread on
or contract a 3D fibrin–fibronectin matrix when the fibronectin is intact (right).
(b) Conditions that support cell adhesion, spreading, and matrix contraction
include cells that express a5b1 and syndecan-4 interacting with a 3D
fibrin–fibronectin matrix (left) or a4b1-expressing cells interacting with 3D
fibrin-fragmented fibronectin matrix (right). Dashed arrows indicate multiple
steps between receptors and cell activities.
www.jidonline.org 75
KS Midwood et al.
Cell–Fibronectin Matrix Interactions During Tissue Repair
not been fully determined. Activation can also be achieved
with exogenous treatments that act directly on the integrin
extracellular domain. These include addition of Mn2þ or
binding of activating antibodies that lock the ectodomain in
an active form (Bazzoni et al., 1995). Treatment with Mn2þ
substantially increased CHOa4 cell adhesion and spreading
on a fibrin–fibronectin matrix (Valenick et al., 2005).
Furthermore, matrix contraction by activated CHOa4 cells
was equivalent to CHOa5 cell contraction. Thus, with
appropriate stimulation of a4b1 activity, the integrin is able
to function similarly to a5b1.
As healing progresses, the provisional matrix is remodeled,
exposing a4b1-positive cells to fibronectin fragments in the
wound. Proteolysis of purified fibronectin has been shown to
generate sites for integrin binding in vitro (Ugarova et al.,
1995; Ugarova et al., 1996), which prompted us to test
whether a4b1 interactions with fibronectin were modulated
during provisional matrix turnover. Fibronectin fragments
generated by chymotrypsin digestion were incorporated into
the fibrin 3D matrix. Biochemical analyses showed that
fibronectin fragments were crosslinked to fibrin by factor XIIIa
during the polymerization reaction. Interestingly, CHOa4
cells embedded in the fibrin-fragmented fibronectin matrix
were capable of matrix contraction equivalent to that of
CHOa5 cells (Valenick et al., 2005). Furthermore, contrac-
tion was ablated by function-blocking anti-a4b1 antibodies
showing dependence on a4b1–fibronectin interactions. Frag-
mentation of fibronectin had no stimulatory effect on CHOa5
cell contraction. Thus, the absence of functional interactions
between a4b1 and fibronectin in a provisional matrix can be
completely reversed by fragmentation of fibronectin in the
matrix. In addition to previously identified functions for
fibronectin fragments that include competitive inhibitor
activities and induction of cell migration and gene expression
(Huhtala et al., 1995; Schenk et al., 2003), our results add
regulation of cell adhesion and contractility. Furthermore, we
suggest that matrix turnover, in addition to matrix composi-
tion, provides spatial and temporal control of cell functions
during wound repair. A provisional matrix containing intact
fibronectin could limit the extent of a4b1-mediated adhesion
and matrix contraction (Figure 1a, right) but as fibronectin is
degraded, for example, as the provisional matrix is replaced
by granulation tissue, fibronectin fragments bind more avidly
to a4b1, providing an adhesive environment (Figure 1b,
right). The stimulatory effect of fibronectin fragmentation
suggests that the CS1 binding site for a4b1 is cryptic but its
exposure is enhanced during matrix turnover, perhaps
through conformational changes in fibronectin domains or
other provisional matrix components that otherwise block
cell adhesive sites.
FIBRONECTIN MATRIX DEPOSITION AND THE
MICROENVIRONMENT
One of the primary roles of fibroblasts in wound repair is
deposition of new matrix to rebuild damaged tissue. What are
the factors within the wound that contribute to fibronectin
matrix deposition and its regulation? We examined the
assembly of fibronectin fibrils in the provisional matrix
model and observed that tenascin-C downregulated fibro-
nectin deposition in a RhoA-dependent manner (Midwood
and Schwarzbauer, 2002). In fitting with our data, chemically
induced dermatitis in tenascin-C-null mice leads to disorga-
nized ECM and ear thickening, suggesting deregulated matrix
synthesis in the absence of tenascin-C. Conversely, these null
mice have reduced fibronectin in dermal and corneal wounds
compared to normal mice (reviewed in Mackie and Tucker,
1999). Apparently, the in vivo role of tenascin-C in ECM
assembly is both tissue- and injury-specific.
The level of ECM production may depend on the local
microenvironment as we have found using a 3D matrix
model to study regulation of matrix assembly. This model is
derived from highly confluent fibroblasts that have accumu-
lated a dense fibrillar matrix. Extraction to remove the cells
leaves behind a 3D fibrillar network composed primarily of
fibronectin (Mao and Schwarzbauer, 2005b). Cells are then
plated onto this 3D matrix and a combination of biochemical
and microscopic approaches are used to follow fibronectin
assembly. Comparison to the standard monolayer culture
system routinely used to dissect fibronectin matrix assembly
has allowed us to show a stimulatory effect of a 3D
environment on this process.
Using a variety of fibroblast cell lines that produce their
own fibronectin and CHO cells that require exogenous
fibronectin to carry out matrix assembly, we showed that
fibronectin fibrils accumulate more rapidly, at lower cell
density, and with lower amounts of fibronectin when cells are
in a 3D matrix environment than when on a fibronectin-
coated 2D surface (Mao and Schwarzbauer, 2005b). The
effect is not due to stimulation of fibronectin synthesis.
Immunofluorescence after 6 hours of assembly showed that
the fibrils were longer and denser, extending between
neighboring cells. In contrast, over the same period on 2D
substrates, fibronectin fibrils were short and mostly extended
from the cell surface to an adjacent area on the substrate
rather than to neighboring cells.
The architecture of the 3D matrix plays a crucial role in
stimulating assembly (Mao and Schwarzbauer, 2005b).
Disrupting the 3D organization in a variety of ways including
compressing the 3D matrix from 9 mm down to o3mm
drastically reduced the stimulation of fibril formation. Thus,
the architecture and the three-dimensionality of the micro-
environment are important to stimulate new matrix assembly.
Of major significance was our finding that a 3D
microenvironment stimulates matrix assembly by integrins
that would not normally assemble fibronectin fibrils (Mao
and Schwarzbauer, 2005b). We used two cell lines pre-
viously shown to express activation-dependent integrins,
HT1080 fibrosarcoma tumor cells (Brenner et al., 2000) and
CHOavb3 cells (Wu et al., 1996). For either of these cell
lines, plating on the 3D matrix was sufficient to induce
fibronectin assembly in the absence of any exogenous
integrin activators. These results indicate that this 3D
microenvironment converts the integrins to an activated
state. It is possible that interactions with the 3D matrix
stimulate formation of novel intracellular complexes that are
able to convert the integrins into an active form, thus
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stimulating assembly. Whatever the mechanism, it raises the
interesting possibility that cells encountering an appropriate
3D matrix in vivo will be induced to assemble additional
ECM. Upregulation of ECM assembly may also contribute to
increased cell–cell cohesion in vivo as recently demonstrated
using a hanging drop cell culture system (Robinson et al.,
2004). During wound repair, then, it is critical to control the
extent of matrix protein synthesis and cell receptor activity in
order to rebuild damaged tissue while at the same time
limiting the amount of new matrix assembly. If not properly
controlled, excess ECM deposition or overactive integrin
receptors would most likely delay wound closure and force
cells within the wound bed into a fibroproliferative state.
CONCLUSION
Our studies of 3D fibronectin matrices and their effects on
cell activities have highlighted several ways in which cell
interactions with fibronectin matrix can be modulated during
repair. Changes in ECM architecture or composition, such as
deposition of tenascin-C, downregulate fibronectin signals
and change cells from stationary to motile phenotypes with
requisite modulation of signaling through FAK, Rho, and
probably other intracellular pathways. Accumulation of a
fibronectin-rich fibrillar matrix has stimulatory effects on
further matrix deposition while generation of fibronectin
fragments during matrix turnover can have inhibitory or
stimulatory effects on cell–matrix interactions. In these
examples, the receptor repertoire plays a key role, not only
requiring specific integrins but also co-receptors such as
syndecan-4. An issue that was not highlighted here is the
contributions of signals from other extracellular molecules,
such as growth factors or cytokines, to the effects of ECM.
This signal integration adds another layer of regulation onto
the complexities of cell–ECM interactions that drive the
wound healing process.
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